GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » YoY EPS Growth

BetterLife Pharma (STU:NPAU) YoY EPS Growth : 0.00% (As of Jan. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. BetterLife Pharma's YoY EPS Growth for the quarter that ended in Jan. 2024 was 0.00%.

BetterLife Pharma's Earnings per Share (Diluted) for the three months ended in Jan. 2024 was €-0.01.


BetterLife Pharma YoY EPS Growth Historical Data

The historical data trend for BetterLife Pharma's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma YoY EPS Growth Chart

BetterLife Pharma Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -32.01 3.35 87.05 38.39 69.57

BetterLife Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.00 75.86 12.50 97.30 -

BetterLife Pharma YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

BetterLife Pharma's YoY EPS Growth for the fiscal year that ended in Jan. 2024 is calculated as:

YoY EPS Growth (A: Jan. 2024 )
=(Earnings per Share (Diluted) (A: Jan. 2024 )-Earnings per Share (Diluted) (A: Jan. 2023 ))/ | Earnings per Share (Diluted) (A: Jan. 2023 ) |
=(-0.021--0.069)/ | -0.069 |
=69.57 %

BetterLife Pharma's YoY EPS Growth for the quarter that ended in Jan. 2024 is calculated as:

YoY EPS Growth (Q: Jan. 2024 )
=(Earnings per Share (Diluted) (Q: Jan. 2024 )-Earnings per Share (Diluted) (Q: Jan. 2023 )) / | Earnings per Share (Diluted) (Q: Jan. 2023 )) |
=(-0.007-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BetterLife Pharma YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma (STU:NPAU) Business Description

Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines